Breaking News

Cedarburg Hauser Site Granted DEA Registration

Denver facility can manufacture schedule II-V controlled substances

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cedarburg Hauser’s Denver, CO facility has been granted registration as a manufacturer of schedule II-V controlled substances by the U.S Drug Enforcement Agency (DEA). The new DEA registration status allows the company to manufacture controlled substances and provides additional capacity when added to its existing controlled substance manufacturing capabilities at its Grafton, WI facility.   “The GMP manufacturing and analytical method development expertise of Cedarburg Hauser’s Denv...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters